Please Wait
Applying Filters...
menu
    • menu
    Kewpie-PSE
    News
    Consolidated business results for fiscal year ended Nov 30 2024

    09 Jan 2025

    // PRESS RELEASE

    Supplementary Data for the FY Ended Nov 30 2024

    09 Jan 2025

    // PRESS RELEASE

    Notice regarding Formulation of Medium-Term Business Plan

    25 Nov 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Kewpie Corporation

    Contact Supplier

    Website

    CPhI Japan

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/a9474wUfYEQ
    Menu

    Kewpie Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Sodium hyaluronate, Intrinsic viscosity 2.93 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Contact Kewpie Corporation and get a quotation

    Kewpie Corporation is a supplier offers 4 products (APIs, Excipients or Intermediates).

    Find a price of Sodium Hyaluronate bulk with DMF, CEP, JDMF offered by Kewpie Corporation

    Find a price of Sodium Hyaluronate bulk with DMF, JDMF offered by Kewpie Corporation

    Find a price of Hyaluronic Acid bulk with JDMF offered by Kewpie Corporation

    Find a price of Sodium Hyaluronate bulk with JDMF offered by Kewpie Corporation